GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
13.9619 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
13.1027 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AXL, BCL2, CA3, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, HSD17B2, IGF1R, MMP2, MMP9, OPRK1, OPRM1, PDE3A, PDE3B, POLB, SRC, TYR |
10.6209 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, AXL, BCL2, CA2, CA3, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP4, FLT3, HSD17B2, HTR2A, HTR2C, IGF1R, KDR, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, POLB, SRC, TYR |
9.66057 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, AXL, BCL2, CA2, CA3, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP4, FLT3, HSD17B2, IGF1R, KDR, MMP2, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, POLB, SRC, TYR |
9.66057 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, BCL2, CA3, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, HTR2A, HTR2C, KDR, OPRK1, OPRM1, PDE3A, POLB, SRC |
8.58636 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, AXL, BCL2, CA3, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, KDR, OPRD1, OPRK1, POLB, SRC |
8.34673 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX5, AOX1, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HTR2C, PDE10A, PDE3A, PDE3B, PIM1, TBXAS1, TYR, XDH |
7.93356 |
[BP] GO:0007200 |
None
|
CHRM2, DRD1, DRD2, ESR1, HTR2A, HTR2C, OPRD1, OPRK1, OPRM1 |
7.84218 |
[BP] GO:0014070 |
response to organic cyclic compound
|
BCL2, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FLT3, OPRK1, OPRM1, PDE3A, SRC, TYR |
7.79521 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA12, CA2, CA7, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, F2, FABP4, FLT3, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2C, HTR7, KDR, MET, OPRD1, OPRK1, OPRM1, PDE3A, POLA1, POLB, SRC, XDH |
7.78446 |
[BP] GO:0033993 |
response to lipid
|
AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FLT3, HSD17B2, OPRK1, OPRM1, SRC, TYR |
6.92514 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TYR |
6.51486 |
[BP] GO:0007187 |
None
|
CHRM2, CNR1, CNR2, DRD1, DRD2, HTR1A, HTR7, OPRD1, OPRK1, OPRM1 |
6.42358 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA3, CA2, CHRM2, CNR1, CNR2, DRD1, DRD2, ESR1, F2, HTR1A, HTR2A, HTR2C, HTR7, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, SIGMAR1, SRC |
6.42358 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, DRD2, ESR1, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2C, OPRK1 |
6.1548 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, DRD1, DRD2, F2, HTR2A, HTR2C, KDR, SRC |
5.9655 |
[BP] GO:0007188 |
None
|
CHRM2, CNR1, DRD1, DRD2, HTR1A, HTR7, OPRD1, OPRK1, OPRM1 |
5.82777 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA3, AKR1B1, AURKB, AXL, BCL2, CA2, CA3, CA6, CA9, CHRM2, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, F2, FABP4, FLT3, HSD17B2, HTR1A, HTR2A, HTR2C, IGF1R, KDR, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, POLA1, POLB, SRC, TYR |
5.81995 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, BCL2, CA2, CA7, CNR1, DRD1, DRD2, F2, HTR2A, HTR2C, KDR, OPRK1, SRC |
5.62051 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, ALOX5, AXL, BCL2, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRB, F2, FABP4, HSD17B2, HTR1A, HTR2A, HTR2C, HTR7, IGF1R, MET, MMP1, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PIM1, SRC, TYR |
5.56991 |
[BP] GO:0007165 |
signal transduction
|
ADORA3, AKR1B1, AXL, BCL2, CA1, CA2, CHRM2, CNR1, CNR2, CSNK2A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F2, FLT3, HTR1A, HTR2A, HTR2C, HTR7, IGF1R, KDR, MET, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, PIM1, POLB, SIGMAR1, SRC |
5.53832 |
[BP] GO:0007193 |
None
|
CHRM2, DRD2, HTR1A, HTR7, OPRD1, OPRK1, OPRM1 |
5.52839 |
[BP] GO:0038003 |
None
|
OPRD1, OPRK1, OPRM1, SIGMAR1 |
5.42501 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX5, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F2, FABP4, FLT3, HSD17B1, HSD17B2, HTR1A, HTR2C, IGF1R, KDR, MET, MMP1, MMP2, PDE10A, PDE3A, PDE3B, PIM1, POLA1, POLB, SENP6, SRC, TBXAS1, TYR, XDH |
5.34599 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2 |
5.29506 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F2, FLT3, HTR1A, HTR2A, HTR2C, IGF1R, KDR, MET, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, SRC, XDH |
5.25331 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DRD1, ESR1, ESRRA, FLT3, IGF1R, MMP2, OPRK1, OPRM1, PDE3A, PDE3B, SRC |
5.24069 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F2, FLT3, HTR1A, HTR2A, HTR2C, IGF1R, KDR, MET, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, SRC, XDH |
5.14263 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, SRC |
4.9003 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, SRC |
4.88953 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F2, FLT3, HTR2A, HTR2C, KDR, MET, MMP9, OPRK1, OPRM1, SRC, XDH |
4.88518 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F2, FLT3, HTR2A, HTR2C, KDR, MET, MMP9, OPRK1, OPRM1, SRC, XDH |
4.86382 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, ESR1, F2, FLT3, HTR2A, HTR2C, IGF1R, KDR, MET, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, SRC, XDH |
4.86382 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, AXL, BCL2, CA12, CA2, CA7, CNR1, DRD1, DRD2, ESR1, F2, FABP4, FLT3, HTR2A, HTR2C, MET, POLA1, POLB, SRC |
4.78949 |
[BP] GO:0099536 |
None
|
CHRM2, CNR1, DRD1, DRD2, HTR2A, HTR2C, HTR7, OPRD1, OPRK1, OPRM1 |
4.78949 |
[BP] GO:0099537 |
None
|
CHRM2, CNR1, DRD1, DRD2, HTR2A, HTR2C, HTR7, OPRD1, OPRK1, OPRM1 |
4.78949 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, AXL, BCL2, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, SRC |
4.78599 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
CA2, CA7, CNR1, CNR2, DRD2 |
4.68839 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.67429 |
[BP] GO:0043269 |
regulation of ion transport
|
BCL2, CA2, CA7, CNR1, DRD1, DRD2, F2, HTR1A, HTR2A, MMP9, OPRD1, OPRK1, OPRM1 |
4.60545 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, ALOX5, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F2, FABP4, FLT3, HSD17B1, HSD17B2, HTR1A, HTR2C, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, POLA1, POLB, SENP6, SRC, TBXAS1, TYR, XDH |
4.47673 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, HSD17B1, HSD17B2 |
4.45358 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.39002 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, CNR1, CNR2, DRD1, DRD2, FLT3, IGF1R, MMP2, OPRK1, OPRM1, PDE3A, PDE3B, SRC, TYR |
4.3601 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA3, AKR1B1, BCL2, CSNK2A1, CYP1B1, DRD2, ESR1, ESRRA, F2, FLT3, HTR1A, HTR2A, IGF1R, KDR, MMP2, MMP9, OPRM1, PIM1, SRC, XDH |
4.31714 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.31714 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2 |
4.26472 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, KDR, POLB, SRC, TYR |
4.24526 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, HTR1A, TYR |
4.22435 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD2, ESR1, FABP4, HSD17B1, HSD17B2, MET, PDE3A, TBXAS1 |
4.15857 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA2, CA9, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, F2, FABP4, FLT3, HSD17B2, HTR2A, KDR, MET, MMP2, MMP9, PDE3A, PDE3B, PIM1, POLB, SIGMAR1, SRC, TYR |
4.08836 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F2, FLT3, HTR1A, HTR2A, HTR2C, IGF1R, KDR, MET, MMP1, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PIM1, SRC, XDH |
4.04663 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA3, AKR1B1, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F2, FABP4, HTR2A, HTR2C, IGF1R, KDR, MET, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PIM1, SRC, XDH |
4.03189 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, CNR1, CNR2, DRD1, DRD2, FLT3, IGF1R, MMP2, OPRK1, OPRM1, PDE3A, PDE3B, SRC, TYR |
4.03189 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, ESR1, HTR7, OPRK1, OPRM1, SRC |
4.03189 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, POLA1, POLB, SRC |
4.03189 |
[BP] GO:0007268 |
None
|
CHRM2, DRD1, DRD2, HTR2A, HTR2C, HTR7, OPRD1, OPRK1, OPRM1 |
3.94672 |
[BP] GO:0098916 |
None
|
CHRM2, DRD1, DRD2, HTR2A, HTR2C, HTR7, OPRD1, OPRK1, OPRM1 |
3.94672 |
[BP] GO:2001023 |
None
|
CNR1, DRD1, DRD2, HTR2A, MET, OPRK1 |
3.94672 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, HTR2A, OPRK1 |
3.93205 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, AXL, BCL2, CYP1B1, DRD2, F2, FLT3, HTR2A, HTR2C, KDR, MET, OPRK1, OPRM1, SRC, XDH |
3.92943 |
[BP] GO:0072523 |
None
|
AOX1, PDE10A, PDE3A, PDE3B, XDH |
3.84494 |
[BP] GO:0007631 |
None
|
DRD1, DRD2, HTR2C, OPRD1, OPRK1, OPRM1 |
3.80112 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, HTR2A, MMP2, OPRD1, OPRK1, OPRM1, POLB, SRC, TYR |
3.79768 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1 |
3.769 |
[BP] GO:0019233 |
None
|
CNR1, CNR2, OPRD1, OPRK1, OPRM1 |
3.74647 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, CYP2D6, DRD2, ESR1, FABP4, IGF1R, MET, MMP9, OPRM1, PIM1, SRC |
3.72639 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CSNK2A1, DRD2, ESR1, F2, FLT3, HTR1A, HTR2A, IGF1R, KDR, MMP2, MMP9, PIM1 |
3.71882 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1 |
3.71761 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.67065 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR2C, HTR7 |
3.67065 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR2C, HTR7 |
3.67065 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1 |
3.63044 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, ESR1, FLT3, HTR1A, MET, PIM1, POLA1, SRC, TYR |
3.59036 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, FLT3, IGF1R, KDR, MET, MMP9, PDE3A, PIM1, SIGMAR1, SRC, XDH |
3.59036 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FLT3, OPRK1, PDE3B, SRC |
3.56043 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA3, AXL, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F2, HTR1A, HTR2A, HTR2C, IGF1R, KDR, MET, MMP9, OPRD1, OPRK1, OPRM1, SRC |
3.53486 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA3, AXL, BCL2, CA2, CHRM2, CNR1, CYP1B1, DRD2, ESR1, ESRRA, ESRRB, F2, HTR2A, HTR2C, KDR, MET, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PIM1, SRC, XDH |
3.46302 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, BCL2, CA12, CA2, CA7, CNR1, DRD1, DRD2, ESR1, F2, FABP4, HTR2A, HTR2C, MET |
3.44015 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, DRD2, F2, OPRM1 |
3.43451 |
[BP] GO:0014059 |
None
|
CNR1, DRD2, HTR2A, OPRK1 |
3.43045 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, CNR2, DRD1, DRD2, HTR2A |
3.40997 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
BCL2, DRD1, DRD2, ESRRB, F2, FLT3, HTR2A, HTR2C, KDR, MMP9, OPRD1, OPRK1, OPRM1, SRC, XDH |
3.39252 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
BCL2, DRD1, DRD2, ESRRB, F2, FLT3, HTR2A, HTR2C, KDR, MMP9, OPRD1, OPRK1, OPRM1, SRC, XDH |
3.39252 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F2, FABP4, FLT3, HTR1A, HTR2A, HTR2C, IGF1R, KDR, MET, MMP1, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PIM1, SRC, XDH |
3.37736 |
[BP] GO:0002209 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.32653 |
[BP] GO:0001662 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.32653 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA3, AKR1B1, ALOX5, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F2, FABP4, FLT3, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2C, HTR7, IGF1R, KDR, MET, MMP1, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, PIM1, POLA1, POLB, SENP6, SIGMAR1, SRC, TBXAS1, TYR, XDH |
3.31097 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, AURKB, AXL, BCL2, CA3, CSNK2A1, DRD1, DRD2, FLT3, HTR2C, IGF1R, KDR, MET, PDE10A, PDE3A, PDE3B, PIM1, POLB, SRC, XDH |
3.30095 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, BCL2, CNR2, DRD1, DRD2, ESR1, ESR2, HTR2A, IGF1R, MET, MMP9, OPRK1, OPRM1, PDE3B, SRC, XDH |
3.28353 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, BCL2, CNR2, DRD1, DRD2, ESR1, ESR2, HTR2A, IGF1R, MET, MMP9, OPRK1, OPRM1, PDE3B, SRC, XDH |
3.26937 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA3, AKR1B1, AXL, BCL2, CA2, CA3, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, F2, HTR1A, HTR2C, MMP2, MMP9, OPRD1, OPRK1, OPRM1, POLA1, POLB, SRC |
3.25212 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
BCL2, DRD2, ESRRB, F2, FLT3, HTR2A, HTR2C, KDR, MMP9, OPRD1, OPRK1, OPRM1, SRC, XDH |
3.25212 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
AXL, CNR1, CNR2, CYP1A1, CYP1A2, OPRK1, OPRM1, SRC |
3.24599 |
[BP] GO:0043278 |
None
|
CNR1, DRD2, OPRK1, OPRM1 |
3.24288 |
[BP] GO:0014072 |
None
|
CNR1, DRD2, OPRK1, OPRM1 |
3.24288 |
[BP] GO:0042596 |
None
|
BCL2, DRD1, HTR1A, HTR2C |
3.24288 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, DRD2, ESRRA, F2, FABP4, FLT3, HTR2A, HTR2C, KDR, MET, MMP2, MMP9, OPRK1, OPRM1, SRC, XDH |
3.23595 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.23595 |
[BP] GO:0048583 |
regulation of response to stimulus
|
AKR1B1, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, F2, FABP4, FLT3, HTR2A, HTR2C, IGF1R, KDR, MET, MMP2, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, SRC, XDH |
3.23595 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, HTR2A, HTR2C, OPRM1 |
3.23595 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, FLT3, IGF1R, KDR, MET, MMP9, PDE3A, PIM1, SIGMAR1, SRC, XDH |
3.22121 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.21419 |
[BP] GO:0007154 |
None
|
AXL, BCL2, CHRM2, CNR1, DRD1, DRD2, ESR2, HTR2A, HTR2C, HTR7, OPRD1, OPRK1, OPRM1 |
3.17387 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, AXL, BCL2, CA2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, F2, FLT3, HSD17B2, KDR, MMP9, PIM1, POLB, SIGMAR1, SRC, TYR |
3.17083 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA3, AKR1B1, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F2, FABP4, HTR2A, HTR2C, IGF1R, KDR, MET, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PIM1, SRC, XDH |
3.1469 |
[BP] GO:0051952 |
None
|
CNR1, DRD1, DRD2, HTR2A, OPRK1 |
3.11805 |
[BP] GO:0042325 |
regulation of phosphorylation
|
BCL2, DRD1, DRD2, ESRRB, F2, FABP4, FLT3, HTR2A, HTR2C, IGF1R, KDR, MMP9, OPRD1, OPRK1, OPRM1, SRC, XDH |
3.10351 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, FLT3, IGF1R, KDR, MMP9, PDE3A, PIM1, SIGMAR1, SRC, XDH |
3.10251 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
AXL, CNR1, CNR2, CYP1A1, CYP1A2, OPRK1, OPRM1, SRC |
3.08197 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AXL, CYP1B1, DRD1, ESR1, IGF1R, MMP2, MMP9, OPRK1, PDE3A, PDE3B, SRC |
3.07838 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, F2, FLT3, HTR2A, HTR2C, KDR, MET, MMP9, OPRK1, OPRM1, SRC, XDH |
3.07644 |
[BP] GO:0007267 |
None
|
CHRM2, CNR1, DRD1, DRD2, ESR2, HTR2A, HTR2C, HTR7, OPRD1, OPRK1, OPRM1 |
3.07613 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, AURKB, AXL, BCL2, CA3, CSNK2A1, DRD1, DRD2, FLT3, HTR2C, IGF1R, KDR, MET, PDE10A, PDE3A, PDE3B, PIM1, POLB, SRC, XDH |
3.07169 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD17B1, HSD17B2, TBXAS1, TYR, XDH |
3.06133 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, AXL, BCL2, CNR1, CYP19A1, CYP1A1, DRD1, ESR1, ESRRB, HSD17B2, MMP2, MMP9, OPRK1, OPRM1, PDE3A, SRC |
3.05649 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, CA2, CA7, CNR1, CNR2, DRD1, DRD2, HTR2A |
3.05353 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, CA2, CA7, CNR1, CNR2, DRD1, DRD2, HTR2A |
3.05353 |
[BP] GO:0030534 |
None
|
DRD1, DRD2, HTR2A, OPRD1, OPRK1, OPRM1 |
3.03479 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
BCL2, DRD1, DRD2, F2, FABP4, FLT3, HTR2A, HTR2C, IGF1R, KDR, MMP9, OPRD1, OPRK1, OPRM1, SRC, XDH |
2.97473 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, HTR1A, TYR |
2.95225 |
[BP] GO:0003008 |
None
|
AKR1B1, BCL2, CNR1, CNR2, CYP1B1, DRD1, DRD2, HTR1A, HTR2A, HTR7, OPRD1, OPRK1, OPRM1, PDE3A, SRC, TYR |
2.95225 |
[BP] GO:0009410 |
None
|
CNR1, CNR2, DRD1, DRD2, OPRK1, OPRM1 |
2.94071 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, CNR1, DRD1, DRD2, F2 |
2.90619 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.90619 |
[BP] GO:0007610 |
None
|
BCL2, CNR1, DRD1, DRD2, HTR1A, HTR2A, HTR2C, OPRD1, OPRK1, OPRM1 |
2.87875 |
[BP] GO:0060359 |
None
|
CNR1, DRD1, DRD2, OPRK1, OPRM1 |
2.87875 |
[BP] GO:0007208 |
None
|
HTR2A, HTR2C |
2.87875 |
[BP] GO:0031635 |
None
|
OPRK1, OPRM1 |
2.87875 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.87875 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
BCL2, DRD2, F2, FLT3, HTR2A, HTR2C, KDR, MMP9, OPRD1, OPRK1, OPRM1, SRC, XDH |
2.85771 |
[BP] GO:0006195 |
None
|
PDE10A, PDE3A, PDE3B, XDH |
2.83904 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FLT3, HTR2A, HTR2C, SRC |
2.83904 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.83904 |
[BP] GO:0006198 |
None
|
PDE10A, PDE3A, PDE3B |
2.83904 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1 |
2.83904 |
[BP] GO:0003018 |
None
|
DRD1, HTR1A, HTR2A, HTR7, PDE3A, SRC |
2.83904 |
[BP] GO:0023052 |
None
|
CHRM2, CNR1, DRD1, DRD2, ESR2, HTR2A, HTR2C, HTR7, OPRD1, OPRK1, OPRM1 |
2.7187 |
[BP] GO:0050433 |
None
|
CNR1, DRD2, HTR2A, OPRK1 |
2.70074 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP4, MMP1, MMP2, MMP9, PDE10A, PDE3A, PDE3B, SRC, XDH |
2.67481 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.67481 |
[BP] GO:0006939 |
None
|
DRD1, DRD2, HTR2A, HTR7 |
2.67076 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
CYP1A1, CYP1B1, DRD1, ESR1, FLT3, OPRM1, PDE3A, SRC |
2.65278 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1 |
2.65278 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, AXL, BCL2, CA2, CA7, CNR1, CYP19A1, DRD1, DRD2, F2, HTR1A, HTR2A, HTR2C, MMP9, OPRD1, OPRK1, OPRM1, SRC |
2.61249 |
[BP] GO:0009214 |
None
|
PDE10A, PDE3A, PDE3B |
2.60691 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, SRC |
2.59011 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, SRC |
2.57908 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MET, MMP9, PDE3A, PIM1, SRC |
2.57908 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
CNR1, CYP1A1, F2, FLT3, HTR2A, HTR2C, PDE3B, SRC |
2.5678 |
[BP] GO:0046883 |
regulation of hormone secretion
|
CNR1, CYP19A1, DRD2, HTR1A, HTR2A, HTR2C, OPRK1 |
2.56654 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, F2, FLT3, IGF1R, KDR, MET, SENP6, SRC |
2.5415 |
[BP] GO:0006721 |
terpenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, PDE3A |
2.5356 |
[BP] GO:0007626 |
None
|
DRD1, DRD2, HTR2C, OPRD1, OPRK1, OPRM1 |
2.5356 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.52305 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.52305 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, ESRRB, F2, HTR2A, KDR, MET, MMP9, OPRM1, PDE3A, PIM1, SRC |
2.51534 |
[BP] GO:0033555 |
multicellular organismal response to stress
|
BCL2, DRD1, HTR1A, HTR2C |
2.50934 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, CSNK2A1, DRD1, DRD2, HTR1A |
2.50934 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA3, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, IGF1R, KDR, MET, MMP9, OPRK1, SRC |
2.50152 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.50026 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.50026 |
[BP] GO:0033602 |
None
|
CNR1, DRD2 |
2.50026 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.50026 |
[BP] GO:0009187 |
None
|
HTR2C, PDE10A, PDE3A, PDE3B |
2.49673 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.47603 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
BCL2, DRD1, DRD2, ESRRB, F2, FABP4, FLT3, HTR2A, HTR2C, IGF1R, KDR, MMP9, OPRD1, OPRK1, OPRM1, SRC, XDH |
2.46386 |
[BP] GO:0051282 |
None
|
DRD1, DRD2, F2, HTR2A, HTR2C |
2.46386 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.4484 |
[BP] GO:0072347 |
None
|
CNR1, DRD2, OPRK1, OPRM1 |
2.4484 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
BCL2, DRD1, DRD2, ESRRB, F2, FABP4, FLT3, HTR2A, HTR2C, IGF1R, KDR, MMP9, OPRD1, OPRK1, OPRM1, SRC, XDH |
2.4322 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, KDR, OPRM1, SRC |
2.43066 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA3, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, IGF1R, KDR, MET, MMP9, SRC |
2.40633 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
CNR1, DRD1, DRD2, HTR2A |
2.40012 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.39488 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
AKR1B1, DRD1, DRD2, HTR2A, MET |
2.39383 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
DRD2, FLT3, HTR2A, HTR2C, KDR, OPRK1, OPRM1, SRC, XDH |
2.39383 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, DRD1, IGF1R, MMP2, OPRM1, PDE3A, PDE3B, SRC |
2.37961 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
BCL2, CA12, CA2, CA7, DRD1, DRD2, ESR1, F2, HTR2A, HTR2C |
2.37918 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
DRD2, HTR2A, HTR2C, KDR, OPRM1, SRC |
2.36988 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
CNR1, CNR2, CYP19A1, DRD1, DRD2, ESR1, F2, FABP4, KDR, MET, OPRM1 |
2.36797 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, AXL, CYP1B1, KDR, OPRD1 |
2.36797 |
[BP] GO:0070482 |
response to oxygen levels
|
BCL2, CYP1A1, DRD2, MMP2, OPRD1, POLB, SRC |
2.36703 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, ESR1, IGF1R, MET, MMP9, PDE3B, SRC, XDH |
2.36703 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.36248 |
[BP] GO:0042391 |
None
|
BCL2, CNR1, CNR2, DRD1, KDR, OPRD1, OPRM1, SRC |
2.35696 |
[BP] GO:0042698 |
ovulation cycle
|
AXL, OPRK1, OPRM1 |
2.35696 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.35696 |
[BP] GO:0051094 |
positive regulation of developmental process
|
AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, ESRRB, HTR2A, HTR2C, KDR, OPRM1, PDE3A, PIM1, SRC |
2.33236 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
F2, FLT3, HTR2A, HTR2C, SRC |
2.33236 |
[BP] GO:0009166 |
None
|
PDE10A, PDE3A, PDE3B, XDH |
2.31922 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2 |
2.31196 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.30579 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, PDE3A |
2.30572 |
[BP] GO:0003013 |
None
|
DRD1, HTR1A, HTR2A, HTR7, PDE3A, SRC |
2.30399 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MET, MMP9, PDE3A, PIM1, SRC |
2.30399 |
[BP] GO:0050795 |
None
|
CNR1, DRD2, HTR1A, HTR2A |
2.30399 |
[BP] GO:0051881 |
regulation of mitochondrial membrane potential
|
BCL2, KDR, OPRD1, SRC |
2.30399 |
[BP] GO:0043207 |
response to external biotic stimulus
|
AXL, BCL2, CHRM2, CNR1, CNR2, CYP1A1, CYP1A2, F2, OPRK1, OPRM1, SRC |
2.28179 |
[BP] GO:0007198 |
None
|
HTR1A, HTR7 |
2.28179 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.28179 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.28179 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.28179 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA2, CA7, DRD1, DRD2, ESR1, F2, HTR2A, HTR2C |
2.27536 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.27178 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD2, FABP4, MET, PDE3A, TBXAS1 |
2.26412 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, SRC |
2.24915 |
[BP] GO:0009314 |
response to radiation
|
AURKB, BCL2, DRD1, DRD2, OPRK1, OPRM1, POLB, TYR |
2.2338 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA3, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, IGF1R, KDR, MET, MMP9, SRC |
2.2252 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, CNR1, CYP19A1, DRD2, HTR1A, HTR2A, HTR2C, OPRK1, OPRM1, SRC |
2.21861 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, DRD1, ESR1, FLT3, IGF1R, MMP2, OPRM1, PDE3A, PDE3B, SRC |
2.2149 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, AXL, CNR1, CYP1A1, DRD1, ESR1, OPRK1, OPRM1, SRC |
2.21318 |
[BP] GO:1901292 |
None
|
PDE10A, PDE3A, PDE3B, XDH |
2.20593 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, DRD1, IGF1R, MMP2, OPRM1, PDE3A, PDE3B, SRC |
2.20355 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
BCL2, CNR1, CNR2, CYP19A1, DRD1, DRD2, ESR1, ESR2, F2, IGF1R, MET, MMP9, PDE3B, SRC, XDH |
2.2021 |
[BP] GO:0031644 |
None
|
HTR2C, OPRD1, OPRK1, OPRM1 |
2.18838 |
[BP] GO:0001975 |
None
|
CNR2, DRD1, DRD2 |
2.18838 |
[BP] GO:0010038 |
response to metal ion
|
BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9 |
2.18196 |
[BP] GO:0009607 |
response to biotic stimulus
|
AXL, BCL2, CHRM2, CNR1, CNR2, CYP1A1, CYP1A2, F2, OPRK1, OPRM1, SRC |
2.1533 |
[BP] GO:0009966 |
regulation of signal transduction
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, ESR1, ESR2, F2, FLT3, HTR2A, HTR2C, IGF1R, KDR, MET, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, SRC, XDH |
2.14906 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FLT3, HTR2A, HTR2C, SRC |
2.14873 |
[BP] GO:0034762 |
None
|
BCL2, CA2, DRD1, DRD2, F2, MMP9, OPRK1, OPRM1 |
2.14213 |
[BP] GO:0030003 |
cellular cation homeostasis
|
BCL2, CA2, CA7, DRD1, DRD2, ESR1, F2, HTR2A, HTR2C |
2.13366 |
[BP] GO:0043271 |
negative regulation of ion transport
|
BCL2, CNR1, DRD2, HTR2A, MMP9 |
2.11431 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MMP9, PDE3A, PIM1, SRC |
2.11018 |
[BP] GO:0042755 |
None
|
OPRD1, OPRK1, OPRM1 |
2.11018 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.11018 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.11018 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2C |
2.11018 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, AOX1, AURKB, AXL, BCL2, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, DRD1, DRD2, ESR1, F2, FLT3, HTR1A, HTR2C, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, POLB, SENP6, SRC, TYR, XDH |
2.11018 |
[BP] GO:0032845 |
None
|
BCL2, DRD2, HTR2A, HTR2C, SRC |
2.08351 |
[BP] GO:0007568 |
aging
|
AURKB, BCL2, CNR1, CYP1A1, HTR2A, POLB |
2.08351 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
DRD2, FLT3, HTR2A, HTR2C, IGF1R, KDR, OPRK1, OPRM1, SRC, XDH |
2.07477 |
[BP] GO:0042310 |
None
|
HTR1A, HTR2A, HTR7 |
2.0722 |
[BP] GO:0006873 |
cellular ion homeostasis
|
BCL2, CA2, CA7, DRD1, DRD2, ESR1, F2, HTR2A, HTR2C |
2.0722 |
[BP] GO:1901361 |
None
|
AOX1, CYP19A1, CYP1A1, CYP1A2, PDE10A, PDE3A, PDE3B, XDH |
2.06305 |
[BP] GO:0046427 |
positive regulation of JAK-STAT cascade
|
AKR1B1, CYP1B1, F2, FLT3 |
2.05963 |
[BP] GO:0035265 |
organ growth
|
BCL2, CYP19A1, ESR1 |
2.03382 |
[BP] GO:0009154 |
None
|
PDE10A, PDE3A, PDE3B |
2.03382 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AXL, BCL2, CA3, CYP1B1, MMP9, SRC |
2.02193 |
[BP] GO:1904894 |
positive regulation of STAT cascade
|
AKR1B1, CYP1B1, F2, FLT3 |
2.02193 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
AURKB, BCL2, CSNK2A1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F2, FLT3, HTR2A, HTR2C, IGF1R, KDR, MET, MMP9, OPRD1, OPRK1, OPRM1, SRC, XDH |
2.01818 |
[BP] GO:0001763 |
morphogenesis of a branching structure
|
BCL2, DRD2, ESR1, MET, SRC |
2.01647 |
[BP] GO:0051046 |
None
|
ACHE, CNR1, CYP19A1, DRD2, HTR1A, HTR2A, HTR2C, OPRK1, OPRM1, SRC |
2.01195 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
BCL2, DRD2, F2, FLT3, HTR2A, HTR2C, KDR, MMP9, OPRD1, OPRK1, OPRM1, SRC, XDH |
2.0077 |
[BP] GO:0042220 |
None
|
CNR1, DRD2, OPRM1 |
2.00438 |
[BP] GO:0009261 |
None
|
PDE10A, PDE3A, PDE3B |
2.00438 |
[BP] GO:0001659 |
None
|
DRD1, DRD2, HTR2A |
2.00438 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2 |
2.00438 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA3, AXL, CA4, CHRM2, CNR1, CNR2, DRD1, DRD2, FLT3, HTR1A, HTR2A, HTR2C, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
4.9433 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA3, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, FLT3, HTR1A, HTR2A, HTR2C, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
4.60545 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA3, AXL, CA2, CA4, CA9, CHRM2, CNR1, CNR2, DRD1, DRD2, F2, FLT3, HTR1A, HTR2A, HTR2C, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1, SRC |
3.44015 |
[CC] GO:0098590 |
plasma membrane region
|
CA2, CA4, CA9, CHRM2, CNR1, DRD1, DRD2, HTR2A, MET, OPRD1, OPRM1, SIGMAR1, SRC |
2.72585 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA3, ALOX5, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, F2, FLT3, HSD17B2, HTR1A, HTR2A, HTR2C, HTR7, IGF1R, KDR, MET, MMP2, OPRD1, OPRK1, OPRM1, PDE10A, PDE3B, PIM1, SIGMAR1, SRC, TBXAS1, TYR |
2.7187 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA3, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, F2, FLT3, HSD17B2, HTR1A, HTR2A, HTR2C, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, SIGMAR1, SRC, TBXAS1, TYR |
2.70625 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA3, AXL, CA12, CA14, CA2, CA4, CA9, CHRM2, CNR1, CNR2, CSNK2A1, DRD1, DRD2, ESR1, F2, FLT3, HTR1A, HTR2A, HTR2C, HTR7, IGF1R, KDR, MET, MMP2, OPRD1, OPRK1, OPRM1, PIM1, SRC |
2.50589 |
[CC] GO:0043679 |
None
|
CHRM2, DRD2, OPRD1, OPRK1 |
2.49673 |
[CC] GO:0044463 |
None
|
AKR1B1, CA4, CA9, CHRM2, CNR1, DRD1, DRD2, HTR2A, OPRD1, OPRK1, OPRM1, SIGMAR1, SRC |
2.46386 |
[CC] GO:0120038 |
None
|
AKR1B1, CA4, CA9, CHRM2, CNR1, DRD1, DRD2, HTR2A, OPRD1, OPRK1, OPRM1, SIGMAR1, SRC |
2.46386 |
[CC] GO:0043204 |
None
|
CNR2, DRD2, OPRK1, OPRM1, PDE10A |
2.43291 |
[CC] GO:0031253 |
None
|
CA4, CA9, DRD1, DRD2, OPRD1, OPRM1, SRC |
2.20593 |
[CC] GO:0044306 |
None
|
CHRM2, DRD2, OPRD1, OPRK1 |
2.18838 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
20.2026 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PIM1, TBXAS1, TYR, XDH |
14.0701 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, POLB |
13.148 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
13.0818 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F2, FABP4, FLT3, HSD17B1, HTR1A, HTR2A, HTR2C, HTR7, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, POLA1, POLB, SRC, TBXAS1, TYR, XDH |
11.8707 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, AOX1, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F2, HTR1A, HTR2A, HTR2C, HTR7, MMP1, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, POLA1, POLB, TBXAS1, TYR, XDH |
10.6216 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, POLB |
8.82213 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA3, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F2, FLT3, HTR1A, HTR2A, HTR2C, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
8.25702 |
[MF] GO:0004872 |
receptor activity
|
ADORA3, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F2, FLT3, HTR1A, HTR2A, HTR2C, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
7.26974 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA3, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F2, FLT3, HTR1A, HTR2A, HTR2C, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
7.00523 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA3, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F2, FLT3, HTR1A, HTR2A, HTR2C, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
6.47037 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, ALOX5, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, F2, FLT3, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, POLA1, POLB, SENP6, SRC, TBXAS1, TYR, XDH |
6.42358 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9 |
6.23808 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, AOX1, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, F2, MMP1, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, POLA1, POLB, TBXAS1, TYR, XDH |
6.09611 |
[MF] GO:0099528 |
None
|
CHRM2, HTR1A, HTR2A, HTR2C, HTR7, OPRM1 |
5.79374 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, FLT3, HTR2A, HTR2C, IGF1R, KDR, MET, PDE10A, PIM1, SIGMAR1, SRC |
5.79374 |
[MF] GO:0030594 |
None
|
CHRM2, DRD1, DRD2, HTR1A, HTR2A, HTR2C, HTR7, OPRM1 |
5.79374 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1, XDH |
5.79374 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, HTR1A, HTR2A, HTR2C, HTR7 |
5.62051 |
[MF] GO:0004985 |
None
|
OPRD1, OPRK1, OPRM1, SIGMAR1 |
5.42501 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.29506 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA3, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, FLT3, HTR1A, HTR2A, HTR2C, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
5.25331 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA3, AXL, CHRM2, CNR1, CNR2, DRD1, DRD2, FLT3, HTR1A, HTR2A, HTR2C, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1 |
5.25331 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.05943 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1, TYR |
4.95521 |
[MF] GO:0008227 |
None
|
CHRM2, DRD2, HTR1A, HTR2A, HTR2C, HTR7 |
4.89816 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR2C, HTR7 |
4.88953 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR2C, HTR7 |
4.88953 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, SRC, TBXAS1 |
4.2308 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, SRC, TBXAS1 |
4.03434 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
4.03189 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD17B1, POLA1, SRC, TBXAS1, XDH |
3.94672 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD17B1, HSD17B2, TBXAS1, TYR, XDH |
3.84494 |
[MF] GO:0004930 |
None
|
ADORA3, CHRM2, CNR1, CNR2, DRD1, DRD2, HTR1A, HTR2A, HTR2C, HTR7, OPRD1, OPRK1, OPRM1, SIGMAR1 |
3.77623 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2A, HTR2C, HTR7 |
3.77623 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1, TYR |
3.77623 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR2C, HTR7 |
3.67065 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR2C, HTR7 |
3.67065 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.46127 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.06034 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD17B1 |
2.90619 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.87875 |
[MF] GO:0004119 |
None
|
PDE3A, PDE3B |
2.87875 |
[MF] GO:0071886 |
None
|
HTR2A, HTR2C |
2.87875 |
[MF] GO:0047555 |
None
|
PDE10A, PDE3A, PDE3B |
2.83904 |
[MF] GO:0004115 |
None
|
PDE10A, PDE3A, PDE3B |
2.748 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB |
2.64367 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB |
2.64367 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.52305 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.51671 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.50026 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB |
2.40012 |
[MF] GO:0042923 |
None
|
OPRD1, OPRK1, OPRM1 |
2.35696 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.28179 |
[MF] GO:0004114 |
None
|
PDE10A, PDE3A, PDE3B |
2.27178 |
[MF] GO:0004112 |
None
|
PDE10A, PDE3A, PDE3B |
2.2252 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AOX1, HSD17B1, HSD17B2, XDH |
2.17943 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.11018 |